75.20
0.25 (0.33%)
| Previous Close | 74.95 |
| Open | 74.92 |
| Volume | 141,036 |
| Avg. Volume (3M) | 1,159,232 |
| Market Cap | 13,010,576,384 |
| Price / Earnings (TTM) | 34.65 |
| Price / Earnings (Forward) | 13.09 |
| Price / Sales | 1.52 |
| Price / Book | 3.85 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 19 Aug 2025 |
| Profit Margin | 4.56% |
| Operating Margin (TTM) | 7.73% |
| Diluted EPS (TTM) | 2.14 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | -42.20% |
| Total Debt/Equity (MRQ) | 242.58% |
| Current Ratio (MRQ) | 1.19 |
| Operating Cash Flow (TTM) | 772.00 M |
| Levered Free Cash Flow (TTM) | 1.05 B |
| Return on Assets (TTM) | 3.72% |
| Return on Equity (TTM) | 10.66% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | Solventum Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | 4.0 |
| Average | 0.75 |
|
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Value |
| % Held by Insiders | 20.00% |
| % Held by Institutions | 67.82% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Trian Fund Management, L.P. | 31 Mar 2025 | 8,462,819 |
| 52 Weeks Range | ||
| Median | 87.00 (15.69%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 19 May 2025 | 87.00 (15.69%) | Buy | 75.77 |
| 09 May 2025 | 78.00 (3.72%) | Hold | 70.23 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 18 Jun 2025 | Announcement | Solventum Named a Best Company to Work for by U.S. News & World Report |
| 03 Jun 2025 | Announcement | Solventum to Participate in the 2025 Goldman Sachs Health Care Conference |
| 08 May 2025 | Announcement | Solventum to Participate in the 2025 BofA Securities Health Care Conference |
| 08 May 2025 | Announcement | Solventum Reports First Quarter 2025 Financial Results |
| 17 Apr 2025 | Announcement | Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |